Yesterday (3/31/2020), we got a letter from the FDA regarding claims about the COVID-19 virus, for which Carbon 60 (C60) is not an approved treatment. Therefore, no claims can be made about what it does.
We responded immediately by removing all statements about the virus from our websites and literature, in full compliance with the FDA’s request. You can find our response to the FDA here.
We apologize for any confusion this may have caused and thank you for your interest in FullerLifeC60. We reiterate our commitment to transparency and to exceeding your expectations.